Analysts expect ArriVent BioPharma, Inc. to report revenue of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.00.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.75 M | 6.36 M | 6.05 M | 5.42 M | 31.24 M | 40.09 M | ||||||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.77 M | 5.43 M | 5.41 M | 5.01 M | 26.97 M | 32.92 M | ||||||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.26 M | 5.90 M | 5.73 M | 5.21 M | 29.10 M | 36.51 M |
Analysts expect ArriVent BioPharma, Inc. to report earnings per share of -0.99 for Q3 26, against a range of -1.02 to -0.96. The most recent reported quarter, Q2 26, came in at -1.05, a 8.2% miss against the -0.97 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.61 | -0.60 | -1.90 | -0.90 | -0.83 | -0.84 | -0.96 | -1.05 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.96 | -0.58 | -0.59 | -0.69 | -0.80 | -0.83 | -0.82 | -0.89 | -0.96 | -1.10 | -0.92 | -0.92 | -1.01 | -1.10 | -0.58 | -0.37 | ||||||||||
| Low Estimate | -1.12 | -0.66 | -0.65 | -0.81 | -0.88 | -0.97 | -0.88 | -1.05 | -1.02 | -1.20 | -1.02 | -1.08 | -1.13 | -1.22 | -0.68 | -0.43 | ||||||||||
| Consensus Estimate | -1.04 | -0.62 | -0.62 | -0.75 | -0.84 | -0.90 | -0.85 | -0.97 | -0.99 | -1.15 | -0.97 | -1.00 | -1.07 | -1.16 | -0.63 | -0.40 |
Pull Wall Street consensus for ArriVent BioPharma, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=AVBP&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "AVBP", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=AVBP&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();